These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30014612)

  • 21. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract.
    Kommineni S; Bretl DJ; Lam V; Chakraborty R; Hayward M; Simpson P; Cao Y; Bousounis P; Kristich CJ; Salzman NH
    Nature; 2015 Oct; 526(7575):719-22. PubMed ID: 26479034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic stability of the antagonistic character of Enterococcus faecalis ssp. liquefaciens and the detection of a new inhibitory bacteriocin-like substance.
    Martínez-Bueno M; Gálvez A; Maqueda M; Valdivia E
    Folia Microbiol (Praha); 1990; 35(2):113-23. PubMed ID: 2116372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Synthesis of Bioactive Glycovariants of Enterocin 96, an Antimicrobial Peptide from Enterococcus faecalis.
    Nagar R; Rao A
    Methods Mol Biol; 2019; 1954():279-296. PubMed ID: 30864140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and Characterization of Bacteriocin Produced by a Strain of Enterococcus faecalis TG2.
    Xi Q; Wang J; Du R; Zhao F; Han Y; Zhou Z
    Appl Biochem Biotechnol; 2018 Apr; 184(4):1106-1119. PubMed ID: 28952066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PepSAVI-MS Reveals a Proline-rich Antimicrobial Peptide in
    Moyer TB; Heil LR; Kirkpatrick CL; Goldfarb D; Lefever WA; Parsley NC; Wommack AJ; Hicks LM
    J Nat Prod; 2019 Oct; 82(10):2744-2753. PubMed ID: 31557021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virgicin, a novel lanthipeptide from Virgibacillus sp. strain AK90 exhibits inhibitory activity against Gram-positive bacteria.
    Gupta V; Singh SS; Sidhu C; Grover V; Pinnaka AK; Korpole S
    World J Microbiol Biotechnol; 2019 Aug; 35(9):133. PubMed ID: 31432254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of linear forms of the circular enterocin AS-48 obtained by limited proteolysis.
    Montalbán-López M; Spolaore B; Pinato O; Martínez-Bueno M; Valdivia E; Maqueda M; Fontana A
    FEBS Lett; 2008 Sep; 582(21-22):3237-42. PubMed ID: 18760277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of replacing glutamic residues upon the biological activity and stability of the circular enterocin AS-48.
    Sánchez-Hidalgo M; Martínez-Bueno M; Fernández-Escamilla AM; Valdivia E; Serrano L; Maqueda M
    J Antimicrob Chemother; 2008 Jun; 61(6):1256-65. PubMed ID: 18385141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.
    Sandiford S; Upton M
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1539-47. PubMed ID: 22155816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin.
    Ryan MP; McAuliffe O; Ross RP; Hill C
    Lett Appl Microbiol; 2001 Feb; 32(2):71-7. PubMed ID: 11169046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria.
    Ovchinnikov KV; Chi H; Mehmeti I; Holo H; Nes IF; Diep DB
    Appl Environ Microbiol; 2016 Sep; 82(17):5216-24. PubMed ID: 27316965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing bacteriocin biology as targeted therapy in the GI tract.
    Kommineni S; Kristich CJ; Salzman NH
    Gut Microbes; 2016 Nov; 7(6):512-517. PubMed ID: 27624536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a bacteriocin produced by Enterococcus faecalis N1-33 and its application as a food preservative.
    Hata T; Alemu M; Kobayashi M; Suzuki C; Nitisinprasert S; Ohmomo S
    J Food Prot; 2009 Mar; 72(3):524-30. PubMed ID: 19343940
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Yoon JW; Kang SS
    Foodborne Pathog Dis; 2020 Dec; 17(12):764-771. PubMed ID: 32678667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmid pAMS1-encoded, bacteriocin-related "Siblicide" in Enterococcus faecalis.
    Sedgley CM; Clewell DB; Flannagan SE
    J Bacteriol; 2009 May; 191(9):3183-8. PubMed ID: 19270087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer of a plasmid determining bacteriocin Bc-48 production and immunity, and response to sexual pheromones in Enterococcus faecalis S-48.
    Martínez-Bueno M; Valdivia E; Gálvez A; Maqueda M
    Plasmid; 1992 Jul; 28(1):61-9. PubMed ID: 1518913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico prediction and mass spectrometric characterization of botanical antimicrobial peptides.
    Culver KD; Hicks LM
    Methods Enzymol; 2022; 663():157-175. PubMed ID: 35168787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriocin protein BacL1 of Enterococcus faecalis is a peptidoglycan D-isoglutamyl-L-lysine endopeptidase.
    Kurushima J; Hayashi I; Sugai M; Tomita H
    J Biol Chem; 2013 Dec; 288(52):36915-25. PubMed ID: 24235140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterocin F4-9, a Novel O-Linked Glycosylated Bacteriocin.
    Maky MA; Ishibashi N; Zendo T; Perez RH; Doud JR; Karmi M; Sonomoto K
    Appl Environ Microbiol; 2015 Jul; 81(14):4819-26. PubMed ID: 25956765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary characterization of bacteriocins produced by Enterococcus faecium and Enterococcus faecalis isolated from pig faeces.
    du Toit M; Franz CM; Dicks LM; Holzapfel WH
    J Appl Microbiol; 2000 Mar; 88(3):482-94. PubMed ID: 10747229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.